Discoverpoint-of-care toolslike our insurance coverage checker for CGMs and medications and dosing info for T2D
Home
Admin PortalData Dashboard
RESOURCES ∨
NEWS
EVENTS
FOR MEMBERS ∨
VBR ∨
FOR PATIENTS
QUALITY INITIATIVES ∨
ABOUT ∨

GLP-1 Receptor Agonist Shortages: How to Support Patients

Download Resource
Due to the glycemic, weight loss, and cardiovascular benefits of GLP-1 receptor agonists, many of these medications are experiencing short-term shortages. Here are some tips for supporting patients during medication shortages.
This one-page guide, developed by Jonathan Gabison, MD (first author), Lauren Oshman, MD, MPH, FAACP and Heidi Diez, PharmD, provides dosing and titration guidelines for switching between GLP-1 RA/GIPs during the national shortage in the United States, as well as functional tips for navigating medication shortages.
Providers, have you used this tool? Give us your feedback to help improve it for others

Tags:

For ProvidersPDFPoint-of-careCreated-By-MCT2D

Subscribe to the MCT2D Newsletter

* indicates required
Blue Cross Blue Shield Blue Care Network of Michigan

Support for the Michigan Collaborative on Type 2 Diabetes is provided by Blue Cross Blue Shield of Michigan and Blue Care Network as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs. To learn more about Value Partnerships, visit www.valuepartnerships.com. Although Blue Cross Blue Shield of Michigan and the Michigan Collaborative on Type 2 Diabetes work in partnership, the opinions, beliefs, and viewpoints expressed by MCT2D do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.

PATIENT STORIESPOINT-OF-CARE-TOOLSSUBMIT A CASE SUMMARYSUBMIT FEEDBACK